Retour aux projets

18288.1 PFLS-LS

Identification of novel strategies to treat obesity and type 2 diabetes

Résumé

Identification of novel strategies to treat obesity and type 2 diabetes

Textes supplémentaires

Abstract

Obesity and its associated co-morbidities such as type 2 diabetes, hypertension and cardiovascular complications have become a major burden worldwide with limited options for treatment. ETH Zürich and Glycemicon continue their successful collaboration on the application of THBA in type 2 diabetes therapy. In the current project both partners will develop a novel biocatalytic routes for production of THBA and elucidate whether THBA could also be employed a type 2 diabetes treatment in pets. Lastly the project aims to uncover new possibilities for the treatment of obesity through the identification of natural products which induce energy expenditure by activating brown fat.

Participants

Nadia Mrosek

Wirtschaftspartner

nmrosek@glycemicon.com

Glycemicon AG Nadia Mrosek Schorenstrasse 16 8603 Schwerzenbach ZH CH

Christian Wolfrum

Kontaktperson

christian-wolfrum@ethz.ch

ETH Zürich Christian Wolfrum Schorenstrasse 16 8603 Schwerzenbach ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-12-31
Date de fin
2017-12-31
Coûts totaux approuvés
CHF 619968.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%